Figure 1.
cfDNA concentration in healthy controls, MDS patients and AML patients. Levels are shown (ng cfDNA/mL plasma) in plasma samples from healthy controls and patients with MDS or AML. *P ≤ .05; **P ≤ .01.
cfDNA concentration in healthy controls, MDS patients and AML patients. Levels are shown (ng cfDNA/mL plasma) in plasma samples from healthy controls and patients with MDS or AML. *P ≤ .05; **P ≤ .01.